[Federal Register Volume 77, Number 200 (Tuesday, October 16, 2012)]
[Notices]
[Pages 63290-63291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-25478]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-72-2012]


Foreign-Trade Zone 121--Albany, NY; Notification of Proposed 
Production Activity; Albany Molecular Research, Inc., Subzone 121A, 
(Pharmaceutical Chemicals Production), Rensselaer, NY

    Albany Molecular Research, Inc. (AMRI), operator of Subzone 121A, 
submitted a notification of proposed production activity for its 
facility in Rensselaer, New York. The notification conforming to the 
requirements of the regulations of the Board (15 CFR 400.22) was 
received on September 26, 2012.
    Subzone 121A was originally approved by the Board in 1994 for the 
production of bulk pharmaceutical chemicals and intermediates under FTZ 
procedures at the former Sanofi Winthrop L.P. plant located at 33 
Riverside Avenue in Rensselaer, New York, (Board Order 698, 7/20/1994, 
59 FR 18318, 7/28/1994).
    AMRI is now requesting to produce an active pharmaceutical 
ingredient, dexpramipexole dihydrochloride monohydrate, under zone 
procedures at the Rensselaer facility. AMRI plans to transfer the 
active ingredient to another FTZ facility where it will be processed 
into a finished dosage pharmaceutical product (duty-free).
    Production under FTZ procedures could exempt AMRI from customs duty 
payments on the foreign status components used in export production for 
the additional finished product listed above. Production for the 
domestic market would not involve inverted tariff savings since the 
active ingredient is subject to the same duty rate (6.5%) as the 
chemical inputs. Customs duties also could possibly be deferred or 
reduced on foreign status production equipment. The chemicals sourced 
from abroad are (R)-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine and 
propyl 4-methylbenzenesulfonate.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive

[[Page 63291]]

Secretary at the address below. The closing period for their receipt is 
November 26, 2012.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
[email protected] (202) 482-1367.

    Dated: October 11, 2012.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2012-25478 Filed 10-15-12; 8:45 am]
BILLING CODE P